There is a need for research that evaluates the impact of the many changes now occurring in the healthcare system with a particular focus on cancer prevention, control, and treatment. Efforts focusing on improving access to care may also impact inequities that contribute to health disparities. Public health policy initiatives such as the federal and state marketplaces that have expanded insurance coverage, as well as Medicaid expansion in some states, create natural experiments ripe for evaluation. Research to be funded by this RFA should focus on the changes in national, state, and/or local policy and the response to these changes by healthcare systems, insurers, payers, communities, practices, and patients.
A clear understanding of these changes can help clinicians, health systems, public health and public policy professionals, patient and consumer advocates, and providers to identify and guide needed improvements in cancer prevention and control and health care and health more broadly. Findings from this research may also inform advocacy and policy development by the American Cancer Society Cancer Action Network (ACS CAN) in the context of meaningful health care reform by assessing outcomes related to the structure of the health system on availability, administrative simplicity, adequacy, and affordability of coverage, referred to as the 4 A’s, which make up the Society and Cancer Action Network's framework for reform.
We are keenly interested in supporting rapid learning research to study the effects of health policy changes on patients, providers, and health systems. This includes but is not limited to:
Specific examples of potential research areas that may be applicable include the following, organized by the 4 A’s of meaningful healthcare reform:
4. Administrative simplicity
We encourage investigators to submit innovative proposals using an array of study designs which may include interventional or non-interventional research such as case control studies, cohort studies, clinical trials, comparative effectiveness research, dissemination and implementation research, cross-sectional studies, ecological, or mixed methods research. For example:
This RFA will use the Research Scholar Grants (RSG) mechanism. See the Research Scholar Grants section of All Grant Policies and All Grant Instructions for detailed descriptions of the ACS's priority focus on health equity research in the Clinical and Cancer Control Research Grants Program and budget instructions.
Eligibility: You ARE eligible to submit a proposal if you:
Awards may not exceed a period of 4 years, with one exception (see health equity below). It is anticipated that some studies will require no more than two years to complete.
Grant awards of 2-3 years have maximum direct costs of $200K per year, with 20% allowable indirect costs; awards of 4 years have maximum direct costs of $165K per year, with 20% allowable indirect costs.
Multi-level health equity focused applications may propose a project period of up to 5 years and $200K per year, plus 20% allowable indirect costs. Both intervention and non-intervention research is acceptable. If the study is primarily data focused, mixed methods should be utilized to collect both primary data and secondary collection, or both qualitative and quantitative data.
|Award Period||Direct Cost Cap Per Year||Indirect Cost Cap Per Year|
|2 to 3 years||$200,000||20%|
Note: Grant application materials become available early January and July, and applications are due April 1 and October 15.